# Cochlear Implantation: Candidacy and Outcomes

## Overview
Cochlear implants (CIs) are the most successful neural prosthesis in medicine. They bypass damaged cochlear hair cells and directly stimulate the auditory nerve. Candidacy criteria continue to expand, now including single-sided deafness and patients with more residual hearing than historically required.

## Device Components

### External
Microphone: captures sound. Sound processor: converts sound to digital signals (behind-the-ear or off-the-ear). Transmitter coil: magnetically coupled to internal receiver; sends coded signal transcutaneously.

### Internal (Implanted)
Receiver-stimulator: decodes signal, generates electrical impulses. Electrode array: inserted into the scala tympani; typically 12-22 electrodes. Tonotopic stimulation: basal electrodes = high frequency; apical electrodes = low frequency.

## Candidacy Criteria

### Adults (Evolving -- FDA and Centers May Differ)
**Traditional**: bilateral severe-to-profound SNHL with sentence recognition <= 50% in best-aided condition. **Expanded (current trend)**: moderate-to-profound SNHL with sentence scores <= 60% in the ear to be implanted and <= 60% in best-aided binaural condition. Inadequate benefit from optimally fitted hearing aids (minimum 3-month trial). No medical contraindications to surgery, Realistic expectations and motivation for rehabilitation.

### Pediatric
**12 months and older** (FDA approved): bilateral profound SNHL. **9 months and older**: bilateral profound SNHL (some centers, off-label). **2 years and older**: bilateral severe-to-profound SNHL. Limited benefit from hearing aids (defined by age-appropriate speech perception testing). Enrollment in auditory-verbal therapy program. Earlier implantation yields better speech and language outcomes (critical period: before 3-3.5 years).

### Expanding Indications (Controversial)
**Single-sided deafness (SSD)**: FDA approved 2019 for certain devices; CI in the deaf ear to restore binaural hearing, improve sound localization, reduce tinnitus. **Asymmetric hearing loss**: profound loss in one ear with aidable hearing in the other (bimodal -- CI + hearing aid). **Hybrid/electroacoustic stimulation (EAS)**: CI for high-frequency loss + acoustic amplification for preserved low-frequency hearing; shorter electrode arrays. **Elderly patients**: no upper age limit; outcomes comparable to younger adults when cognitively intact.

## Preoperative Evaluation

### Audiologic
Comprehensive audiometry (unaided and aided). Speech perception testing in best-aided condition (CNC words, AzBio sentences). Hearing aid optimization and trial (minimum 3 months with appropriately fitted aids).

### Medical
MRI brain/IAC: assess cochlear nerve, cochlear patency, rule out retrocochlear pathology. CT temporal bone: cochlear anatomy, patency (ossification?), anomalies, mastoid pneumatization. Cochlear ossification (post-meningitis): may require drill-out or split-array insertion.

### Additional
Vestibular assessment (CI can affect residual vestibular function). Psychological/cognitive screening (realistic expectations, ability to participate in rehabilitation). Speech-language pathology evaluation, Genetic counseling (if applicable).

## Surgical Technique

### Approach
Postauricular incision; cortical mastoidectomy. **Posterior tympanotomy (facial recess approach)**: most common; through the triangle formed by the fossa incudis, chorda tympani, and facial nerve. **Round window insertion**: preferred when anatomy permits; atraumatic soft-surgery technique. **Cochleostomy**: drilling anterior-inferior to the round window when RW insertion not feasible. Electrode array gently advanced into the scala tympani.

### Soft Surgery Principles (Hearing Preservation)
Slow, gentle electrode insertion, Round window approach preferred. Topical or systemic steroids to reduce intracochlear inflammation. Avoid suctioning perilymph. Perimodiolar or lateral wall electrode selection based on goals. Goal: preserve residual hearing for electroacoustic stimulation.

### Electrode Array Types

| Array Type | Position | Advantages | Disadvantages |
|-----------|----------|------------|---------------|
| Perimodiolar (pre-curved) | Close to modiolus/spiral ganglion | Lower stimulation thresholds | Higher intracochlear trauma risk |
| Lateral wall (straight) | Along lateral wall of scala tympani | Atraumatic; better hearing preservation | Further from spiral ganglion |
| Short array (EAS/hybrid) | Basal turn only | Preserves apical low-frequency hearing | Limited frequency coverage |

**Perimodiolar (pre-curved)**: sits close to modiolus/spiral ganglion cells; may provide lower stimulation thresholds; higher risk of intracochlear trauma. **Lateral wall (straight)**: sits along the lateral wall of scala tympani; atraumatic insertion; better for hearing preservation. **Short arrays**: for EAS/hybrid -- preserve apical low-frequency hearing. Full insertion: 20-31 mm depending on array.

### Intraoperative Testing
**Impedance telemetry**: confirm electrode function. **Neural response telemetry (NRT/NRI/ART)**: confirm auditory nerve stimulation. **Intraoperative imaging** (X-ray or CT): confirm electrode position, rule out tip foldover.

## Postoperative Management
Device activation at 2-4 weeks postoperatively (allow healing). Serial programming (mapping) sessions: adjust threshold and comfort levels for each electrode. Intensive auditory rehabilitation/therapy essential for optimal outcomes. Follow-up audiometry: aided sound field thresholds and speech perception at regular intervals.

## Outcomes

### Adults
Average sentence recognition: 60-80% in quiet after 12 months. Significant variability based on duration of deafness, age at implantation, etiology, pre-implant speech perception. Better outcomes with shorter duration of deafness. Bilateral CI or bimodal (CI + hearing aid) superior to unilateral CI for speech in noise and localization.

### Pediatric
Children implanted before age 2: speech and language development approaches age-appropriate peers. Children implanted before age 1: even better outcomes. Congenitally deaf children implanted after age 5-7: diminishing returns (critical period effects). Oral communication rates: >80% in early-implanted children.

### Predictors of Good Outcomes
Short duration of deafness, Pre- or peri-lingual deafness with early implantation. Post-lingual deafness (previously developed auditory cortical pathways). Higher pre-implant speech perception, Consistent device use, Robust rehabilitation program.

## Complications

### Surgical
Facial nerve injury (<1%), Chorda tympani injury (taste disturbance), CSF leak (especially with inner ear malformations). Perilymph gusher (enlarged vestibular aqueduct, X-linked deafness). Electrode misplacement (scala vestibuli, tip foldover), Vertigo (transient common; persistent uncommon), Wound infection, hematoma, flap necrosis.

### Device-Related
Device failure requiring reimplantation (1-5% over device lifetime). Magnet displacement, Electrode migration.

### Long-Term
Loss of residual hearing in the implanted ear. Meningitis: slightly increased risk; ensure pneumococcal vaccination. MRI compatibility: newer devices are MRI conditional (1.5T or 3T with magnet removal or specific protocols).

## Bilateral Cochlear Implantation
Superior to unilateral for speech perception in noise, sound localization, and quality of life. Simultaneous vs. sequential: no strong evidence favoring one approach. Insurance coverage increasingly available. Particularly important in pediatric population for binaural auditory development.

<image>Cross-sectional diagram of the cochlea showing a cochlear implant electrode array inserted into the scala tympani via the round window. The electrode array curves along the lateral wall, with individual electrode contacts positioned along the basilar membrane. The organ of Corti, spiral ganglion cells in the modiolus, scala vestibuli, scala media, and scala tympani are labeled. Arrows show electrical stimulation from electrodes to spiral ganglion neurons.</image>

<image>Surgical illustration of the posterior tympanotomy (facial recess) approach for cochlear implantation. View through the mastoidectomy cavity showing the facial nerve in its mastoid segment, the chorda tympani nerve, the fossa incudis with the short process of the incus, and the facial recess triangle between these structures. The round window niche is visible through the facial recess, with the electrode array being inserted. Key anatomical landmarks labeled.</image>

<image>Complete cochlear implant system diagram showing both external and internal components. External: microphone on the BTE processor, connecting cable to the transmitter coil with magnet. Internal: receiver-stimulator package under the scalp, lead wire entering the mastoid, and electrode array in the cochlea. Radiofrequency signal transmission between the external coil and internal receiver is illustrated with arrows. Labeled schematic diagram.</image>

## Clinical Pearls
Cochlear implantation is the most successful neural prosthesis -- outcomes continue to improve with device and surgical advances. Duration of deafness is the single most important predictor of CI outcomes in post-lingually deaf adults. For pediatric patients, implantation before age 2 (ideally before 1) optimizes speech and language development. Round window insertion with soft-surgery technique maximizes hearing preservation for electroacoustic stimulation. Always obtain preoperative MRI to confirm cochlear nerve presence -- aplasia of the cochlear nerve is a contraindication. Post-meningitis patients require urgent evaluation as cochlear ossification can progress rapidly, making electrode insertion impossible. Bilateral cochlear implantation is superior to unilateral for speech in noise and sound localization. Ensure pneumococcal vaccination (PCV13 and PPSV23) before or soon after implantation due to increased meningitis risk.

## References
- Gifford RH, Dorman MF, Skarzynski H, et al. "Cochlear implantation with hearing preservation yields significant benefit for speech recognition in complex listening environments." *Ear Hear*. 2013;34(4):413-425.
- Carlson ML, Driscoll CL, Gifford RH, et al. "Implications of minimizing trauma during conventional cochlear implantation." *Otol Neurotol*. 2011;32(6):962-968.
- Buchman CA, Gifford RH, Haynes DS, et al. "Unilateral cochlear implants for severe, profound, or moderate sloping to profound bilateral sensorineural hearing loss: a systematic review and consensus statements." *JAMA Otolaryngol Head Neck Surg*. 2020;146(10):942-953.
- Niparko JK, Tobey EA, Thal DJ, et al. "Spoken language development in children following cochlear implantation." *JAMA*. 2010;303(15):1498-1506.